• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Computer-Aided Mammograms Increase Medicare Cost-Burden: JAMA Study

Article

The retrospective study analyzed SEER data from 2001 through 2009, and found that the annual CAD prevalence among Medicare screening mammograms increased from 3.5% to 79.7%.

When used during mammograms on women aged 65 and older, computer-aided detection (CAD) leads to more diagnostic intervention, including biopsy, and increases the detection of in situ breast tumors, a new study shows.

breast cancer

"Because in situ tumors often neither grow nor progress, CAD may be leading to a lot of unnecessary breast surgery and radiation in older women who don't really have ," Dr. Joshua J. Fenton, of the University of California Davis, told Reuters Health by email.

Medicare has reimbursed CAD during screening mammography since 2001. In a prior study, Dr. Fenton and colleagues found that CAD use increases the rate of false-positive findings on screening mammography and the detection of ductal carcinoma in situ (DCIS).

Complete report on Medscape: http://bit.ly/108L6LO

Related Videos
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Will Shapiro, vice president of data science, Flatiron Health
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Will Shapiro, vice president of data science, Flatiron Health
Jonathan E. Levitt, Esq, Frier Levitt, LLC
Judy Alberto, MHA, RPh, BCOP, Community Oncology Alliance
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.